Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Last 30 days: 423 accesses
Last 365 days: 4393 accesses
All time: 11317 accesses

Samuel T Henderson^*, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones and Lauren C Costantini